|Articles|December 1, 2002

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components
Volume 8
Issue 18 Suppl

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Author(s)Carolyn E. Schwartz, ScD, Mirjam A.G. Sprangers, PhD

Download PDF: An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Articles in this issue

over 23 years ago

Article

Participating Faculty

over 23 years ago

Article

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components

over 23 years ago

Article

Quality of Life and Symptom Measures in Oncology: An Overview

over 23 years ago

Article

Quality-of-Life Measurements: A Soft Outcome - Or is it?

over 23 years ago

Article

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

over 23 years ago

Article

Continuing Medical Education Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Zanubrutinib Tops Rivals in Real-World CLL Survival Study

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Zanubrutinib Tops Rivals in Real-World CLL Survival Study